Clinical trial

Sarilumab Effect on the Pharmacokinetics of Simvastatin

NCT02017639

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-01-01

PhasePHASE1

Study timeline

Study start (unknown)2014-01-01Date precision: month

Registry last updated2016-04-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

sarilumab SAR153191 (REGN88)DRUG

simvastatinDRUG · verified · RxNorm: simvastatin

Sponsors & collaborators

Sanofilead sponsor

Regeneron Pharmaceuticalscollaborator

Mapped research locations

DallasTexas, United States1 SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02017639 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.